<?xml version="1.0"?>
<Articles JournalTitle="Iranian Journal of Allergy, Asthma and Immunology">
  <Article>
    <Journal>
      <PublisherName>Tehran University of Medical Sciences</PublisherName>
      <JournalTitle>Iranian Journal of Allergy, Asthma and Immunology</JournalTitle>
      <Issn>1735-1502</Issn>
      <Volume>14</Volume>
      <Issue>3</Issue>
      <PubDate PubStatus="epublish">
        <Year>2015</Year>
        <Month>10</Month>
        <Day>18</Day>
      </PubDate>
    </Journal>
    <title locale="en_US">Association between Peptidylarginine Deiminase Type 4 rs1748033 Polymorphism and Susceptibility to Rheumatoid Arthritis in Zahedan, Southeast Iran</title>
    <FirstPage>255</FirstPage>
    <LastPage>260</LastPage>
    <Language>EN</Language>
    <AuthorList>
      <Author>
        <FirstName>Mohammad</FirstName>
        <LastName>Hashemi</LastName>
        <affiliation locale="en_US">Cellular and Molecular Research Center, Zahedan University of Medical Sciences, Zahedan, Iran AND Department of Clinical Biochemistry, School of Medicine, Zahedan University of Medical Sciences, Zahedan, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Zahra</FirstName>
        <LastName>Zakeri</LastName>
        <affiliation locale="en_US">Department of Internal Medicine, School of Medicine, Zahedan University of Medical Sciences, Zahedan, Iran AND Department of Internal Medicine, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Hamed</FirstName>
        <LastName>Taheri</LastName>
        <affiliation locale="en_US">Department of Internal Medicine, School of Medicine, Zahedan University of Medical Sciences, Zahedan, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Gholamreza</FirstName>
        <LastName>Bahari</LastName>
        <affiliation locale="en_US">Department of Clinical Biochemistry, School of Medicine, Zahedan University of Medical Sciences, Zahedan, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Mohsen</FirstName>
        <LastName>Taheri</LastName>
        <affiliation locale="en_US">Genetics of Non Communicable Disease Research Center, Zahedan University of Medical Sciences, Zahedan, Iran</affiliation>
      </Author>
    </AuthorList>
    <History>
      <PubDate PubStatus="received">
        <Year>2015</Year>
        <Month>10</Month>
        <Day>18</Day>
      </PubDate>
      <PubDate PubStatus="accepted">
        <Year>2015</Year>
        <Month>10</Month>
        <Day>18</Day>
      </PubDate>
    </History>
    <abstract locale="en_US">There are controversial reports regarding the role of peptidylarginine deiminase type 4 (PADI4) gene polymorphisms and risk of Rheumatoid arthritis (RA). The aim of the present study was to investigate the impact of PADI4 rs1748033 polymorphism and susceptibility to RA in a sample of the Iranian population.This case-control study was done on 150 patients with RA and 150 healthy subjects.PADI4 rs1748033 genotyping was done using amplification refractory mutation system- polymerase chain reaction (ARMS-PCR) assay.The&#xA0; PADI4&#xA0; rs1748033&#xA0; variant&#xA0; increased&#xA0; the&#xA0; risk&#xA0; of&#xA0; RA&#xA0; in&#xA0; codominant&#xA0; (OR=1.67,95%CI=1.03-2.71, p=0.048, CT vs CC; OR=2.73, 95%CI=1.25-5.97, p=0.013, TT vs CC) and dominant (OR=1.84, 95%CI=1.15-2.92, p=0.014, CT+TT vs CC) tested inheritance models. In addition, the PADI4 rs1748033 T allele increased the risk of RA (OR=1.63,95%CI=1.16-2.29, p=0.006) in comparison with C allele.In conclusion, our finding indicated that PADI4 rs1748033 gene polymorphism increased the risk of RA in a sample of the Iranian population.</abstract>
    <web_url>https://ijaai.tums.ac.ir/index.php/ijaai/article/view/565</web_url>
    <pdf_url>https://ijaai.tums.ac.ir/index.php/ijaai/article/download/565/450</pdf_url>
  </Article>
</Articles>
